Sánchez Jorge, Sánchez Andres, Cardona Ricardo
Group of Experimental and Clinical Allergy, IPS Universitaria, University of Antioquia, Medellín, Colombia.
Foundation for the Development of Medical and Biological Sciences, Cartagena, Colombia.
Allergy Asthma Immunol Res. 2019 Jan;11(1):29-42. doi: 10.4168/aair.2019.11.1.29.
Immunoglobulin (Ig) E autoantibodies against thyroid antigens such as thyroid peroxidase (TPO) have been demonstrated in chronic spontaneous urticaria (CSU) patients in higher frequency than healthy subjects. However, if these IgE autoantibodies can trigger urticaria is still a matter of study. The aim of this study was to investigate the relationship between concomitant IgE autoantibodies against thyroid antigens in CSU.
Patients with CSU, healthy subjects and patients with autoimmune thyroid disease (ATD) were recruited. Total IgE and specific anti-TPO IgE and IgG were assessed in all subjects. The basophil activation test and skin tests with TPO were performed to demonstrate whether this antigen could selectively induce urticaria reaction in subjects with positive anti-TPO IgE.
Anti-TPO IgE was present in all 3 groups (CSU: 34.0%, ATD: 16.6%, healthy subjects: 8.1%). Anti-TPO IgE levels were higher in CSU patients, whereas anti-TPO IgG were higher in ATD patients. After exposure to TPO, CD203c expression from patients with CSU and anti-TPO IgE significantly increased in comparison to the other groups; 33.0% vs. 14.0% in ATD patients and 9.0% in control subjects ( < 0.05). Skin reactions with TPO were higher in patients with CSU according to the intradermal (CSU: 18.0%, ATD: 3.3%, control: 8.0%) and skin prick tests (12.0%, 0%, 0%, respectively). Passive transfer of anti-TPO IgE from a CSU patient to the skin of control subjects without anti-TPO IgE induced a positive skin reaction.
Anti-TPO IgE is not a specific biomarker for CSU. However, IgE against TPO plays a pathogenic role in inducing effector cell activation and skin exacerbation in some patients with CSU.
慢性自发性荨麻疹(CSU)患者体内针对甲状腺抗原如甲状腺过氧化物酶(TPO)的免疫球蛋白(Ig)E自身抗体的检出频率高于健康受试者。然而,这些IgE自身抗体是否能引发荨麻疹仍有待研究。本研究旨在探讨CSU患者中伴随的针对甲状腺抗原的IgE自身抗体之间的关系。
招募CSU患者、健康受试者和自身免疫性甲状腺疾病(ATD)患者。检测所有受试者的总IgE以及特异性抗TPO IgE和IgG。进行嗜碱性粒细胞活化试验和TPO皮肤试验,以证明该抗原是否能在抗TPO IgE阳性的受试者中选择性诱导荨麻疹反应。
三组均存在抗TPO IgE(CSU:34.0%,ATD:16.6%,健康受试者:8.1%)。CSU患者的抗TPO IgE水平较高,而ATD患者的抗TPO IgG水平较高。接触TPO后,CSU患者和抗TPO IgE患者的CD203c表达与其他组相比显著增加;ATD患者为33.0%,对照组为14.0%,健康受试者为9.0%(P<0.05)。根据皮内试验(CSU:18.0%,ATD:3.3%,对照组:8.0%)和皮肤点刺试验(分别为12.0%、0%、0%),CSU患者对TPO的皮肤反应更高。将CSU患者的抗TPO IgE被动转移至无抗TPO IgE的对照受试者皮肤可诱导阳性皮肤反应。
抗TPO IgE不是CSU的特异性生物标志物。然而,针对TPO的IgE在一些CSU患者中对诱导效应细胞活化和皮肤症状加重起致病作用。